Ohio State Navbar

Sign In

RSS Feed BMI News


Guest Lecture: Kevin R. Coombes, PhD Thursday, June 7 

 

​Kevin Coombes is a Professor in the Department of Bioinformatics and Computational Biology at the UT M.D. Anderson Cancer Center.  He received his Ph.D. in pure mathematics in 1982 from the University of Chicago and. worked for many years in the areas of algebraic K-theory and arithmetic algebraic geometry (while rising through the academic ranks at MIT, University of Michigan, and University of Maryland in College Park). In the mid 1990’s, he shifted his research interests to bioinformatics.  He received awards for “Best Presentation” at the 2001 and 2002 CAMDA (Critical Assessment of Microarray Data Analysis) conferences, and for “Best Abstract” at the First Annual Proteomics Data Mining Conference.  His current research focuses on statistical, mathematical, and computational methods to process, analyze, and understand highly multivariate biological data arising from high throughput technologies. He is particularly interested in (1) methods that incorporate existing biological knowledge early in the analytical process and (2) methods that integrate diverse types of biological data with a view toward predicting clinically relevant patient outcomes. With his collaborator, Keith Baggerly, he is known for his work in “forensic bioinformatics”, which is an effort to understand and uncover the (often poorly described) methods that were actually used to analyze large data sets.

“Cell Lines, Chemotherapy Response, and the Need for Reproducible Research”

In November 2006, researchers at Duke University published the first in a series of papers that claimed that (1) microarray and drug response data from cancer cell lines could be used to develop genomic signatures of response to specific chemotherpaies, and (2) these signatures successfully predicted patient responses.  Duke later began running clinical trials based on this work.  We attempted to reproduce their analyses on publicly available data, and were unsuccessful.  We identified a series of errors in data provenance and analysis, which we published as letters to editors and as an article in a statistical journal.  As a result of our efforts, four clinical trials have been terminated and at least eight papers have been retracted.  In this talk, I will describe some of the errors we found, some of the "forensic bioinformatics" methods used to discover them, and the efforts that are underway nationally to develop new

tools that promote and enable "reproducible research".​

 

Posted on 6-Jun-12 by System Account
Tags:
 
Trackback Url  |  Link to this post | Bookmark this post with: